DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock

NYSE · Life Sciences Tools & Services · Visualizza su SEC EDGAR ↗
$7,18
Prezzo · Ago 19, 2026
Fondamentali al Ago 6, 2026

Informazioni su Ginkgo Bioworks Holdings, Inc. Class A Common Stock Panoramica della società da Wikipedia

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Leggi di più

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

History

In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.

On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.

Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.

On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.

On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.

On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.

On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.

On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.

On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.

On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.

In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.

Fraud allegations

On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.

In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

DNA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$7.18
Capitalizzazione di Mercato
$443M
P/E (TTM)
-1.3
EPS (TTM)
$-5.64
Ricavi (TTM)
$170M
Rendimento div.
ROE
-55.8%
D/E Debito/Patrimonio
Intervallo 52 sett.
$5 – $18

DNA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $170M
7-point trend, +214.0%
2019-12-31 2025-12-31
EPS $-5.64
7-point trend, -5540.0%
2019-12-31 2025-12-31
Flusso di cassa libero $-179M
4-point trend, +41.3%
2022-12-31 2025-12-31
Margini -183.8%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
DNA
Mediana dei peer
P/E (TTM)
5-point trend, +99.4%
-1.3
17.5
P/S (TTM)
4-point trend, -98.9%
2.6
3.3
P/B
4-point trend, -98.7%
0.9
2.1
Price / FCF (Prezzo / FCF)
4-point trend, +99.4%
-2.5

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
DNA
Mediana dei peer
Operating Margin (Margine Operativo)
4-point trend, +59.9%
-185.3%
Net Profit Margin (Margine di Profitto Netto)
4-point trend, +58.3%
-183.8%
-56.5%
ROA
4-point trend, +72.6%
-25.1%
-17.2%
ROE
4-point trend, +57.9%
-55.8%
-41.3%
ROIC
4-point trend, +51.1%
-61.8%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
DNA
Mediana dei peer
Current Ratio (Rapporto corrente)
4-point trend, -41.4%
4.9
4.9
Quick Ratio
4-point trend, -42.4%
4.7

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
DNA
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, -45.8%
-25.1%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, -45.8%
-29.1%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, -45.8%
17.3%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
DNA
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, -305.8%
$-5.64

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
DNA
Mediana dei peer

DNA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

VENDI 10 analisti
  • Acquisto forte 0 0,0%
  • Compra 1 10,0%
  • Mantieni 2 20,0%
  • Vendi 5 50,0%
  • Vendita forte 2 20,0%

Target Price a 12 Mesi

2 analisti · 2026-08-15
Target mediano $7.00 -2,5%
Target medio $7.00 -2,5%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.05%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $-0.75 $-0.92 0.17%
31 Marzo 2026 $-1.39 $-1.09 -0.30%
31 Dicembre 2025 $-1.41 $-1.47 0.06%
30 Settembre 2025 $-1.45 $-1.25 -0.20%
30 Giugno 2025 $-1.10 $-1.58 0.48%
31 Marzo 2025 $-1.68 $-1.79 0.11%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
DNA $484M -1.5 -25.1% -183.8% -55.8%
AZTA $1.32B -23.5 3.5% -9.4% -3.3% 45.5%
CYRX $479M 6.9 12.4% 44.4% 15.3% 47.1%
MLAB $489M 73.1 3.4% 2.7% 3.7% 63.5%
CTKB $649M 505.0 0.52% -33.0% -18.5% 51.8%
OABI
PACB $565M -1.0 3.9% -341.5% -1634.9% 28.6%
TKNO $204M -11.9 7.3% -42.6% -23.8% 33.2%
LAB $495M -6.4 -6.2% -87.8% -17.6% 49.9%
CDXS $147M -3.3 18.6% -62.5% -82.8%
LFCR $249M -5.3 0.47% -30.0% -461.3% 31.3%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15
Dati annuali Conto Economico per DNA
Metrica Tendenza 2025202420232022202120202019
Revenue 7-point trend, +214.0% $170M $227M $251M $478M $314M $77M $54M
R&D Expense 7-point trend, +153.1% $244M $424M $581M $1.05B $1.15B $160M $96M
SG&A Expense 7-point trend, +521.7% $183M $246M $385M $1.43B $863M $38M $29M
Operating Expenses 7-point trend, +285.9% $485M $787M $1.12B $2.69B $2.14B $214M $126M
Operating Income 7-point trend, -340.3% $-315M $-560M $-864M $-2.21B $-1.83B $-137M $-72M
Interest Expense 5-point trend, -96.2% · · $93.0K $106.0K $2M $2M $2M
Other Non-op 6-point trend, -86.2% $2M $12M $-29M $88M $-10M $12M ·
Pretax Income 7-point trend, -161.7% $-314M $-548M $-893M $-2.12B $-1.84B $-125M $-120M
Income Tax 7-point trend, -3904.5% $-837.0K $-479.0K $-71.0K $-15M $-1M $2M $22.0K
Net Income 7-point trend, -162.1% $-313M $-547M $-893M $-2.10B $-1.83B $-127M $-119M
EPS (Basic) 7-point trend, -5540.0% $-5.64 $-10.54 $-18.37 $-50.15 $-1.35 $-0.10 $-0.10
EPS (Diluted) 7-point trend, -5540.0% $-5.64 $-10.54 $-18.37 $-50.20 $-1.39 $-0.10 $-0.10
Shares (Basic) 7-point trend, -95.2% 55,457,676 51,894,639 48,610,507 41,976,537 1,359,849,000 1,274,766,915 1,149,000,417
Shares (Diluted) 7-point trend, -95.2% 55,457,676 51,894,639 48,610,507 41,995,972 1,360,373,000 1,274,766,915 1,149,000,417
EBITDA 4-point trend, +85.7% $-315M $-560M $-864M $-2.21B · · ·
Stato Patrimoniale 28
Dati annuali Stato Patrimoniale per DNA
Metrica Tendenza 2025202420232022202120202019
Cash & Equivalents 7-point trend, -66.2% $167M $562M $944M $1.32B $1.55B $381M $495M
Short-term Investments 2-point trend, +255418000.00 $255M $0 · · · · ·
Receivables 6-point trend, +43.9% $24M $22M $17M $81M $132M $17M ·
Inventory 4-point trend, -98.3% · · $46.0K $4M $3M $3M ·
Prepaid Expense 6-point trend, +18.3% $25M $19M $40M $52M $34M $21M ·
Other Current Assets 4-point trend, -46.8% · · $362.0K $487.0K $698.0K $680.0K ·
Current Assets 6-point trend, +10.6% $472M $603M $1.00B $1.45B $1.72B $427M ·
PP&E (Net) 6-point trend, +37.8% $167M $204M $188M $315M $146M $121M ·
PP&E (Gross) 6-point trend, +128.9% $355M $365M $309M $408M $207M $155M ·
Accum. Depreciation 6-point trend, +456.3% $188M $161M $121M $93M $61M $34M ·
Goodwill 6-point trend, -100.0% · $0 $49M $60M $21M $2M $2M
Intangibles 6-point trend, +1523.6% $53M $73M $83M $111M $22M $3M ·
Other Non-current Assets 6-point trend, +61.1% $9M $55M $58M $89M $44M $6M ·
Total Assets 6-point trend, +65.8% $1.12B $1.38B $1.67B $2.54B $2.07B $675M ·
Accounts Payable 6-point trend, -23.9% $11M $14M $9M $10M $8M $14M ·
Accrued Liabilities 3-point trend, +276.0% · · · $115M $93M $31M ·
Short-term Debt · · · · · $300.0K ·
Current Liabilities 6-point trend, +31.1% $96M $107M $164M $173M $135M $73M ·
Capital Leases 5-point trend, +417078000.00 $417M $439M $222M $413M $0 · ·
Other Non-current Liabilities 6-point trend, +654.5% $23M $17M $24M $31M $36M $3M ·
Total Liabilities 6-point trend, +198.0% $611M $661M $568M $803M $504M $205M ·
Common Stock 6-point trend, -95.3% $6.0K $5.0K $5.0K $190.0K $161.0K $129.0K ·
Paid-in Capital 6-point trend, +616.5% $6.66B $6.56B $6.39B $6.14B $3.80B $929M ·
Retained Earnings 6-point trend, -1214.5% $-6.15B $-5.84B $-5.29B $-4.40B $-2.30B $-468M ·
AOCI 6-point trend, +1851000.00 $2M $-2M $1M $-3M $-2M $0 ·
Stockholders' Equity 6-point trend, +8.2% $509M $716M $1.10B $1.74B $1.57B $470M ·
Liabilities + Equity 6-point trend, +65.8% $1.12B $1.38B $1.67B $2.54B $2.07B $675M ·
Shares Outstanding 6-point trend, -95.5% 58,207,298 54,365,785,000 50,032,873 47,299,399 40,284,804 1,288,596,000 ·
Flusso di cassa 16
Dati annuali Flusso di cassa per DNA
Metrica Tendenza 2025202420232022202120202019
D&A 7-point trend, +448.5% $59M $63M $71M $43M $29M $14M $11M
Stock-based Comp 7-point trend, +10476.7% $82M $112M $230M $1.93B $1.61B $476.0K $771.0K
Deferred Tax 6-point trend, -1364000.00 $-1M $-936.0K $-801.0K $-15M $0 $0 ·
Amort. of Intangibles 7-point trend, +3640.0% $19M $18M $16M $6M $1M $500.0K $500.0K
Restructuring 2-point trend, -41.1% $11M $19M · · · · ·
Operating Cash Flow 7-point trend, -283.0% $-171M $-320M $-296M $-252M $-254M $-136M $-45M
CapEx 7-point trend, -65.5% $8M $63M $41M $52M $57M $58M $22M
Investing Cash Flow 7-point trend, -222.1% $-240M $-62M $-81M $-67M $-73M $-67M $-75M
Stock Issued 3-point trend, +19469000.00 $19M $0 $0 · · · ·
Stock Repurchased · · · · · · $408.0K
Net Stock Activity $19M · · · · · ·
Financing Cash Flow 7-point trend, -95.7% $18M $-2M $-3M $95M $1.53B $90M $410M
Net Change in Cash 7-point trend, -235.1% $-393M $-384M $-380M $-223M $1.21B $-113M $291M
Taxes Paid 6-point trend, +192000.00 $192.0K $0 $23.0K $981.0K $9M $0 ·
Free Cash Flow 4-point trend, +41.3% $-179M $-382M $-336M $-304M · · ·
Levered FCF 2-point trend, -10.4% · · $-336M $-305M · · ·
Redditività 7
Dati annuali Redditività per DNA
Metrica Tendenza 2025202420232022202120202019
Operating Margin 4-point trend, +59.9% -185.3% -246.5% -343.8% -462.4% · · ·
Net Margin 4-point trend, +58.3% -183.8% -240.9% -355.1% -440.6% · · ·
Pretax Margin 4-point trend, +58.5% -184.3% -241.2% -355.1% -444.1% · · ·
EBITDA Margin 4-point trend, +59.9% -185.3% -246.5% -343.8% -462.4% · · ·
ROA 4-point trend, +72.6% -25.1% -36.0% -42.5% -91.3% · · ·
ROE 4-point trend, +57.9% -55.8% -72.3% -76.0% -132.4% · · ·
ROIC 4-point trend, +51.1% -61.8% -78.1% -78.8% -126.3% · · ·
Liquidità e Solvibilità 3
Dati annuali Liquidità e Solvibilità per DNA
Metrica Tendenza 2025202420232022202120202019
Current Ratio 4-point trend, -41.4% 4.9 5.6 6.1 8.4 · · ·
Quick Ratio 4-point trend, -42.4% 4.7 5.4 5.9 8.1 · · ·
Interest Coverage 2-point trend, +55.4% · · -9294.7 -20839.2 · · ·
Efficienza 2
Dati annuali Efficienza per DNA
Metrica Tendenza 2025202420232022202120202019
Asset Turnover 4-point trend, -34.2% 0.1 0.1 0.1 0.2 · · ·
Receivables Turnover 4-point trend, +64.9% 7.4 11.6 5.1 4.5 · · ·
Per Azione 5
Dati annuali Per Azione per DNA
Metrica Tendenza 2025202420232022202120202019
Book Value / Share 4-point trend, +852.1% $8.74 $13.17 $0.55 $0.92 · · ·
Revenue / Share 4-point trend, +978.8% $3.07 $4.38 $0.13 $0.28 · · ·
Cash Flow / Share 4-point trend, -1955.0% $-3.08 $-6.16 $-0.15 $-0.15 · · ·
Cash / Share 4-point trend, +313.0% $2.87 $10.33 $0.47 $0.70 · · ·
EPS (TTM) 5-point trend, -305.8% $-5.64 $-10.54 $-18.37 $-50.20 $-1.39 · ·
Tassi di Crescita 3
Dati annuali Tassi di Crescita per DNA
Metrica Tendenza 2025202420232022202120202019
Revenue YoY 5-point trend, -108.1% -25.1% -9.7% -47.4% 52.2% 309.4% · ·
Revenue CAGR 3Y 3-point trend, -159.9% -29.1% -10.2% 48.6% · · · ·
Revenue CAGR 5Y 17.3% · · · · · ·
Valutazione (TTM) 10
Dati annuali Valutazione (TTM) per DNA
Metrica Tendenza 2025202420232022202120202019
Revenue TTM 5-point trend, -45.8% $170M $227M $251M $478M $314M · ·
Net Income TTM 5-point trend, +82.9% $-313M $-547M $-893M $-2.10B $-1.83B · ·
Market Cap 4-point trend, -99.6% $484M $534M $135.29B $127.90B · · ·
P/E 5-point trend, +99.4% -1.5 -0.9 -3.7 -1.3 -239.1 · ·
P/S 4-point trend, -98.9% 2.8 2.4 538.0 267.7 · · ·
P/B 4-point trend, -98.7% 1.0 0.7 123.3 73.7 · · ·
P / Tangible Book 5-point trend, -99.7% 1.1 0.8 140.2 81.7 351.4 · ·
P / Cash Flow 4-point trend, +99.4% -2.8 -1.7 -457.8 -507.1 · · ·
P / FCF 4-point trend, +99.4% -2.7 -1.4 -402.3 -420.1 · · ·
Earnings Yield 5-point trend, -16059.5% -67.9% -107.3% -27.2% -74.3% -0.42% · ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $170M$227M$251M$478M$314M
Margine Operativo % -185.3%-246.5%-343.8%-462.4%
Utile netto $-313M$-547M$-893M$-2.10B$-1.83B
EPS Diluito $-5.64$-10.54$-18.37$-50.20$-1.39
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Rapporto corrente 4.95.66.18.4
Quick Ratio 4.75.45.98.1
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $-179M$-382M$-336M$-304M

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 205 filer · $269.5M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
39 (+13 vs trimestre precedente) 17 (-11 vs trimestre precedente) 65 (+23 vs trimestre precedente) 35 (-12 vs trimestre precedente) +6.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
VIKING GLOBAL INVESTORS LP $35.449.338 3.577.128 13,16% Azioni
Erste Asset Management GmbH $25.902.147 2.536.939 9,61% Azioni
BAILLIE GIFFORD & CO $23.701.242 2.391.649 8,80% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $20.685.074 2.087.293 7,68% Azioni
Anchorage Capital Group, L.L.C. $17.306.457 1.746.363 6,42% Azioni
STATE STREET CORP $14.591.187 1.472.370 5,41% Azioni
GEODE CAPITAL MANAGEMENT, LLC $10.292.812 1.038.369 3,82% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $9.293.628 937.803 3,45% Azioni
Allianz Asset Management GmbH $7.787.258 785.798 2,89% Azioni
MILLENNIUM MANAGEMENT LLC $6.329.279 638.676 2,35% Azioni
SB INVESTMENT ADVISERS (UK) LTD $6.052.324 610.729 2,25% Azioni
Prescott Group Capital Management, L.L.C. $5.369.684 541.845 1,99% Azioni
GOLDMAN SACHS GROUP INC $5.364.154 541.287 1,99% Azioni
RENAISSANCE TECHNOLOGIES LLC $5.349.973 539.856 1,99% Azioni
BANK OF AMERICA CORP /DE/ $4.760.754 480.399 1,77% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $4.109.677 414.700 1,53% Opzione Call
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $3.910.555 394.607 1,45% Azioni
EXCHANGE TRADED CONCEPTS, LLC $3.555.540 358.783 1,32% Azioni
DIMENSIONAL FUND ADVISORS LP $3.480.392 351.200 1,29% Azioni
TUDOR INVESTMENT CORP ET AL $3.326.886 335.710 1,23% Azioni
VANGUARD FIDUCIARY TRUST CO $3.097.598 312.573 1,15% Azioni
Coastal Bridge Advisors, LLC $2.743.256 276.817 1,02% Azioni
BALANCE CAPITAL PARTNERS L.P. $1.972.179 199.009 0,73% Azioni
ALGERT GLOBAL LLC $1.784.395 180.060 0,66% Azioni
Susquehanna Portfolio Strategies, LLC $1.746.449 176.231 0,65% Azioni
BNP PARIBAS FINANCIAL MARKETS $1.637.935 165.281 0,61% Azioni
PEAK6 LLC $1.619.294 163.400 0,60% Opzione Call
CAXTON ASSOCIATES LLP $1.532.552 154.647 0,57% Azioni
D. E. Shaw & Co., Inc. $1.499.938 151.356 0,56% Azioni
Universal- Beteiligungs- und Servicegesellschaft mbH $1.387.400 140.000 0,51% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1.297.219 130.900 0,48% Opzione Put
CITADEL ADVISORS LLC $1.233.973 124.518 0,46% Azioni
JPMORGAN CHASE & CO $1.154.383 113.064 0,43% Azioni
a16z Capital Management, L.L.C. $1.075.909 108.568 0,40% Azioni
CITADEL ADVISORS LLC $1.073.253 108.300 0,40% Opzione Call
Numerai GP LLC $1.036.606 104.602 0,38% Azioni
AMERICAN CENTURY COMPANIES INC $974.718 98.357 0,36% Azioni
WOLVERINE TRADING, LLC $964.467 72.900 0,36% Opzione Call
Ensign Peak Advisors, Inc $931.332 93.979 0,35% Azioni
Bank of New York Mellon Corp $818.843 82.628 0,30% Azioni
PANAGORA ASSET MANAGEMENT INC $803.592 81.089 0,30% Azioni
MARSHALL WACE, LLP $772.356 77.937 0,29% Azioni
Swiss National Bank $744.865 75.163 0,28% Azioni
ALLSTATE CORP $698.209 70.455 0,26% Azioni
Mariner, LLC $667.488 67.359 0,25% Azioni
IEQ CAPITAL, LLC $624.766 63.044 0,23% Azioni
ALLEN OPERATIONS LLC $613.935 61.951 0,23% Azioni
RHUMBLINE ADVISERS $610.615 61.617 0,23% Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC $609.079 61.461 0,23% Azioni
TWO SIGMA INVESTMENTS, LP $599.099 60.454 0,22% Azioni
BROWN ADVISORY INC $586.731 59.206 0,22% Azioni
BlackRock, Inc. $526.895 53.168 0,20% Azioni
Inspire Investing, LLC $514.338 83.905 0,19% Azioni
EDGEWOOD MANAGEMENT LLC $495.500 50.000 0,18% Azioni
WOLVERINE TRADING, LLC $492.156 37.200 0,18% Opzione Put
Quadrature Capital Ltd $456.732 46.088 0,17% Azioni
MORGAN STANLEY $447.427 45.149 0,17% Azioni
Shay Capital LLC $444.384 44.842 0,16% Azioni
LPL Financial LLC $427.257 43.114 0,16% Azioni
CITIGROUP INC $426.893 43.077 0,16% Azioni
JANE STREET GROUP, LLC $414.238 41.800 0,15% Opzione Call
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $387.709 39.123 0,14% Azioni
Casdin Capital, LLC $361.646 36.493 0,13% Azioni
CITADEL ADVISORS LLC $347.841 35.100 0,13% Opzione Put
Dynamic Technology Lab Private Ltd $347.000 34.996 0,13% Azioni
ALLIANCEBERNSTEIN L.P. $342.005 55.792 0,13% Azioni
GROUP ONE TRADING LLC $326.138 32.910 0,12% Azioni
AlphaQuest LLC $309.788 37.279 0,11% Azioni
Mitsubishi UFJ Asset Management Co., Ltd. $301.532 30.427 0,11% Azioni
Welch & Forbes LLC $297.300 30.000 0,11% Azioni
MetLife Investment Management, LLC $285.111 28.770 0,11% Azioni
AXQ CAPITAL, LP $262.387 26.477 0,10% Azioni
BARCLAYS PLC $258.919 26.127 0,10% Azioni
IMC-Chicago, LLC $240.922 24.311 0,09% Azioni
Man Group plc $239.901 24.208 0,09% Azioni
VANGUARD ASSET MANAGEMENT, Ltd $238.425 24.059 0,09% Azioni
CANADA PENSION PLAN INVESTMENT BOARD $222.975 22.500 0,08% Azioni
Russell Investments Group, Ltd. $222.885 22.491 0,08% Azioni
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $217.356 21.933 0,08% Azioni
Modera Wealth Management, LLC $216.316 21.828 0,08% Azioni
MARTINGALE ASSET MANAGEMENT L P $209.062 21.096 0,08% Azioni
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $203.116 22.345 0,08% Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $189.123 30.852 0,07% Azioni
Walleye Capital LLC $188.944 19.066 0,07% Azioni
Invesco Ltd. $186.209 18.790 0,07% Azioni
Trexquant Investment LP $178.420 18.004 0,07% Azioni
SIMPLEX TRADING, LLC $178.330 17.995 0,07% Azioni
Comprehensive Financial Management LLC $174.971 17.656 0,06% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $172.474 17.404 0,06% Azioni
Boston Standard Wealth Management, LLC $164.995 15.165 0,06% Azioni
DEUTSCHE BANK AG\ $163.763 16.525 0,06% Azioni
Creative Planning $156.974 15.840 0,06% Azioni
Vanguard Global Advisers, LLC $155.904 15.732 0,06% Azioni
Squarepoint Ops LLC $155.478 15.689 0,06% Azioni
MERCER GLOBAL ADVISORS INC /ADV $153.664 15.506 0,06% Azioni
ExodusPoint Capital Management, LP $148.343 14.969 0,06% Azioni
Police & Firemen's Retirement System of New Jersey $146.420 14.775 0,05% Azioni
Entropy Technologies, LP $138.423 13.968 0,05% Azioni
Green Alpha Advisors, LLC $134.241 13.546 0,05% Azioni
VANGUARD GROUP INC $130.733 15.732 0,05% Azioni

Insider aziendali 17 insider · 5 dirigenti · 13 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Jason R Kelly Chief Executive Officer & Founder 28 Luglio 2026 A 3.894.680 0 0 $0
Steven P. Coen Chief Financial Officer 16 Luglio 2026 M 51.438 0 1 $-5.941
Mark E. Dmytruk Chief Financial Officer 20 Maggio 2025 M 46.226 0 0 $0
Reshma P. Shetty President & Founder 28 Luglio 2026 A 12.374.544 0 0 $0
Marie E. Fallon Chief Accounting Officer 01 Maggio 2023 M 183.010 0 0 $0
Sri Kosuri Direttore 11 Giugno 2026 A 24.067 0 0 $0
Ross Fubini Direttore 11 Giugno 2026 A 10.822 0 0 $0
Christian O Henry Direttore 11 Giugno 2026 A 24.310 0 2 $-219.800
Harry Sloan Direttore 11 Giugno 2026 A 271.418 0 0 $0
Shyam Sankar Direttore 12 Giugno 2025 A 72.372 0 0 $0
Kathy Hopinkah Hannan Direttore 11 Giugno 2025 M 15.003 0 0 $0
Myrtle S Potter Direttore 11 Giugno 2025 M 10.822 0 0 $0
Arie Belldegrun Direttore 13 Giugno 2024 A 194.925 0 0 $0
Reshma Kewalramani Direttore 12 Giugno 2024 M 186.002 0 0 $0
Marijn E Dekkers Direttore 12 Giugno 2024 M 386.480 0 0 $0
Eagle Equity Partners III, LLC Direttore 16 Settembre 2021 D 31.590.948 0 0 $0
Barry Canton Proprietario del 10% 28 Luglio 2026 A 12.374.544 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 4 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
Reshma P. Shetty, Barry Canton 14 Febbraio 2025 9,50% Modifica SEC
Jason Kelly ×4 depositi 14 Febbraio 2024 Deposito iniziale SEC
Reshma Shetty, Bartholomew Canton ×4 depositi 14 Febbraio 2024 Deposito iniziale SEC
VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 depositi 04 Marzo 2022 Deposito iniziale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 33 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
THNQ · EXCHANGE TRADED CONCEPTS TRUST 0,84% 321.721 NS 30 Aprile 2026 N-PORT
IDNA · iShares Trust 0,44% 101.324 SH 08 Agosto 2026 Giornaliero
IWC · iShares Trust 0,09% 161.981 SH 08 Agosto 2026 Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust 0,05% 187.206 SH 08 Agosto 2026 Giornaliero
IBB · iShares Trust 0,03% 368.167 SH 08 Agosto 2026 Giornaliero
AVSC · AMERICAN CENTURY ETF TRUST 0,03% 91.425 NS 31 Maggio 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 41.498 SH 08 Agosto 2026 Giornaliero
IWN · iShares Trust 0,03% 442.118 SH 08 Agosto 2026 Giornaliero
IWM · iShares Trust 0,01% 1.226.249 SH 08 Agosto 2026 Giornaliero
RSSL · Global X Funds 0,01% 18.139 NS 30 Aprile 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,01% 549.889 SH 08 Agosto 2026 Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 274.008 SH 08 Agosto 2026 Giornaliero
ITWO · ProShares Trust 0,01% 2.005 NS 31 Maggio 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,01% 112.735 SH 08 Agosto 2026 Giornaliero
SCHA · SCHWAB STRATEGIC TRUST 0,01% 210.534 NS 31 Maggio 2026 N-PORT
UWM · ProShares Trust 0,01% 1.567 NS 31 Maggio 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,01% 16.982 NS 30 Aprile 2026 N-PORT
URTY · ProShares Trust 0,00% 1.584 NS 31 Maggio 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 2.081 NS 31 Maggio 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 4.528 NS 30 Aprile 2026 N-PORT
HDG · ProShares Trust 0,00% 40 NS 31 Maggio 2026 N-PORT
VEGN · ETF Series Solutions 0,00% 252 NS 30 Aprile 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 19.123 NS 30 Aprile 2026 N-PORT
IWV · iShares Trust 0,00% 22.130 SH 08 Agosto 2026 Giornaliero
ITOT · iShares Trust 0,00% 66.432 SH 08 Agosto 2026 Giornaliero
SCHB · SCHWAB STRATEGIC TRUST 0,00% 26.477 NS 31 Maggio 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 3.795 NS 30 Aprile 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 584 NS 30 Aprile 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 1.182 NS 30 Aprile 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 1.489.851 SH 08 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3.264 SH 08 Agosto 2026 Giornaliero
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 504 NS 31 Maggio 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 1.232 NS 30 Aprile 2026 N-PORT